Names have been withheld to protect the intelligent:
What I think is interesting is whether this will become part of P4P proposals. If the government funds these counter-detailers, what happens if a physician refuses to see them? Are they reported to CMS? Are there repercussions for those physicians? Will they get more reimbursement if they see the government counter-detailers? If generic prescribing habits are part of P4P, as some propose, will this be part of it as well. Interesting to think about.
Iâ€™d want to make sure the gov't detailers have to go by the same rules as the Rx companies -- FDA approved claims, FDA approved materials, no off label etc. Isnâ€™t more info good?
PS, good luck getting a gov't employee to get in to see a doctor without pens and pizza if they donâ€™t have cutting edge science to share
And if pharma detailers drive up the cost of Rx, wonâ€™t their detailers do the same?